Promotions & Moves

Madrigal Pharma Appoints President of R&D

Rebecca Taub to head Phase III development of resmetirom in both NASH and earlier stage dyslipidemias

Madrigal Pharmaceuticals, Inc. has promoted Rebecca Taub, M.D., to the newly created position of President of Research & Development.    Dr. Taub has served as Chief Medical Officer and Executive Vice President of Research & Development, of Madrigal  since 2016. She is also a member of the Company’s Board of Directors.   Paul Friedman, M.D., Chairman and CEO of Madrigal, stated, “As we continue to advance resmetirom forward in Phase 3 clinical development in both NASH and earlier sta...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters